全文获取类型
收费全文 | 17329篇 |
免费 | 1469篇 |
国内免费 | 704篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 174篇 |
妇产科学 | 158篇 |
基础医学 | 924篇 |
口腔科学 | 599篇 |
临床医学 | 1505篇 |
内科学 | 2676篇 |
皮肤病学 | 399篇 |
神经病学 | 506篇 |
特种医学 | 665篇 |
外国民族医学 | 1篇 |
外科学 | 1567篇 |
综合类 | 1976篇 |
现状与发展 | 1篇 |
预防医学 | 800篇 |
眼科学 | 152篇 |
药学 | 5035篇 |
4篇 | |
中国医学 | 768篇 |
肿瘤学 | 1524篇 |
出版年
2023年 | 235篇 |
2022年 | 307篇 |
2021年 | 577篇 |
2020年 | 600篇 |
2019年 | 619篇 |
2018年 | 639篇 |
2017年 | 631篇 |
2016年 | 661篇 |
2015年 | 727篇 |
2014年 | 1043篇 |
2013年 | 1754篇 |
2012年 | 1030篇 |
2011年 | 1130篇 |
2010年 | 835篇 |
2009年 | 792篇 |
2008年 | 827篇 |
2007年 | 832篇 |
2006年 | 678篇 |
2005年 | 689篇 |
2004年 | 552篇 |
2003年 | 520篇 |
2002年 | 437篇 |
2001年 | 380篇 |
2000年 | 312篇 |
1999年 | 245篇 |
1998年 | 195篇 |
1997年 | 229篇 |
1996年 | 161篇 |
1995年 | 172篇 |
1994年 | 144篇 |
1993年 | 156篇 |
1992年 | 136篇 |
1991年 | 130篇 |
1990年 | 109篇 |
1989年 | 104篇 |
1988年 | 106篇 |
1987年 | 103篇 |
1986年 | 81篇 |
1985年 | 83篇 |
1984年 | 85篇 |
1983年 | 62篇 |
1982年 | 60篇 |
1981年 | 47篇 |
1980年 | 49篇 |
1979年 | 45篇 |
1978年 | 41篇 |
1977年 | 28篇 |
1976年 | 33篇 |
1975年 | 18篇 |
1974年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 20 毫秒
91.
Solid Organ Transplantation From Hepatitis B Virus–Positive Donors: Consensus Guidelines for Recipient Management 下载免费PDF全文
S. Huprikar L. Danziger‐Isakov J. Ahn S. Naugler E. Blumberg R. K. Avery C. Koval E. D. Lease A. Pillai K. E. Doucette J. Levitsky M. I. Morris K. Lu J. K. McDermott T. Mone J. P. Orlowski D. M. Dadhania K. Abbott S. Horslen B. L. Laskin A. Mougdil V. L. Venkat K. Korenblat V. Kumar P. Grossi R. D. Bloom K. Brown C. N. Kotton D. Kumar 《American journal of transplantation》2015,15(5):1162-1172
Use of organs from donors testing positive for hepatitis B virus (HBV) may safely expand the donor pool. The American Society of Transplantation convened a multidisciplinary expert panel that reviewed the existing literature and developed consensus recommendations for recipient management following the use of organs from HBV positive donors. Transmission risk is highest with liver donors and significantly lower with non‐liver (kidney and thoracic) donors. Antiviral prophylaxis significantly reduces the rate of transmission to liver recipients from isolated HBV core antibody positive (anti‐HBc+) donors. Organs from anti‐HBc+ donors should be considered for all adult transplant candidates after an individualized assessment of the risks and benefits and appropriate patient consent. Indefinite antiviral prophylaxis is recommended in liver recipients with no immunity or vaccine immunity but not in liver recipients with natural immunity. Antiviral prophylaxis may be considered for up to 1 year in susceptible non‐liver recipients but is not recommended in immune non‐liver recipients. Although no longer the treatment of choice in patients with chronic HBV, lamivudine remains the most cost‐effective choice for prophylaxis in this setting. Hepatitis B immunoglobulin is not recommended. 相似文献
92.
Laparoscopic Transplantation Following Transvaginal Insertion of the Kidney: Description of Technique and Outcome 下载免费PDF全文
P. Modi B. Pal S. Kumar J. Modi Y. Saifee R. Nagraj J. Qadri A. Sharmah R. Agrawal M. Modi V. Shah V. Kute H. Trivedi 《American journal of transplantation》2015,15(7):1915-1922
Laparoscopic kidney transplantation (LKT) is well accepted modality of treatment for ESRD patients at our center. Usually, the kidney is inserted through small Pfannenstiel incision. With the permission of the Internal Review Board, we carried out LKT in eight female recipients following insertion of the kidney through the vagina. The kidney was procured by the retroperitoneoscopic approach. Antibiotic prophylaxis was given. All cases were carried out successfully with immediate graft function and 100% graft and patient survival at 1 year of follow‐up. Estimated glomerular filtration rate at 1 month and 1 year was similar to eight randomly selected female recipients who underwent open kidney transplantation (OKT). No analgesia was required in seven out of eight patients after the 3rd postoperative day. In summary, vaginal insertion of kidney and LKT is safe and feasible in a selected group of patients. It is associated with better analgesia and has similar allograft function as compare to OKT. 相似文献
93.
Donor CD4 T Cell Diversity Determines Virus Reactivation in Patients After HLA‐Matched Allogeneic Stem Cell Transplantation 下载免费PDF全文
94.
Rapamycin ameliorates the CTLA4‐Ig–mediated defect in CD8+ T cell immunity during gammaherpesvirus infection 下载免费PDF全文
D. F. Pinelli B. S. Wakeman M. E. Wagener S. H. Speck M. L. Ford 《American journal of transplantation》2015,15(10):2576-2587
Latent viral infections are a major concern among immunosuppressed transplant patients. During clinical trials with belatacept, a CTLA4‐Ig fusion protein, patients showed an increased risk of Epstein–Barr virus‐associated posttransplant lymphoproliferative disorder, thought to be due to a deficient primary CD8+ T cell response to the virus. Using a murine model of latent viral infection, we observed that rapamycin treatment alone led to a significant increase in virus‐specific CD8+ T cells, as well as increased functionality of these cells, including the ability to make multiple cytokines, while CTLA4‐Ig treatment alone significantly dampened the response and inhibited the generation of polyfunctional antigen‐specific CD8+ T cells. However, the addition of rapamycin to the CTLA4‐Ig regimen was able to quantitatively and qualitatively restore the antigen‐specific CD8+ T cell response to the virus. This improvement was physiologically relevant, in that CTLA4‐Ig treated animals exhibited a greater viral burden following infection that was reduced to levels observed in untreated immunocompetent animals by the addition of rapamycin. These results reveal that modulation of T cell differentiation though inhibition of mTOR signaling can restore virus‐specific immune competence even in the absence of CD28 costimulation, and have implications for improving protective immunity in transplant recipients. 相似文献
95.
96.
Comparing Humoral and Cellular Immune Response Against HBV Vaccine in Kidney Transplant Patients 下载免费PDF全文
Host protection upon vaccination usually results from the complex interplay of humoral and cellular components of the immune system. Exploring hepatitis B surface antigen (HBsAg)‐specific T cell responses and their correlation with humoral responses under immunosuppression, we analyzed 51 renal transplant recipients, differing in HBV vaccine–specific antibody titers (non [NRs]‐, low [LRs]‐, and high responders [HRs]) and in 22 healthy controls (HCs) in a cross‐sectional study. HBsAg‐specific T cells were analyzed by flow cytometry according to expression of activation markers CD40L and/or CD69, and the cytokines IFNγ, IL‐2, TNFα, and IL‐17. No significant differences in responder rate and magnitude of HBsAg‐specific T cell responses were found between HCs and HRs. Interestingly, HBsAg‐specific Th‐cells were also observed in 50% of humoral NRs. Frequencies of HBsAg‐specific CD40L+ Th‐cells were significantly higher in HRs compared to LRs (p = 0.009) and in LRs in comparison to NRs (p = 0.043). All but NRs showed a predominance of multi‐potent HBsAg‐specific TNFα+IL‐2+ Th‐cells. As expected, HBsAg‐specific CD8+ T cells were rarely found. In conclusion, mounting of hepatitis B vaccine‐specific T cell responses is possible in kidney transplant recipients despite immunosuppression. Detection of HBV‐specific Th‐cells in a significant proportion of humoral NRs contributes to the current discussion on conferring immune protection by cellular memory in such patients. 相似文献
97.
Immunophenotypic Profile and Increased Risk of Hospital Admission for Infection in Infants Born to Female Kidney Transplant Recipients 下载免费PDF全文
E. Ono A. M. dos Santos P. O. Viana M. I. S. Dinelli N. Sass L. De Oliveira A. L. Goulart M. I. de Moraes‐Pinto 《American journal of transplantation》2015,15(6):1654-1665
Children born to female kidney recipients are exposed to immunosuppressive drugs during gestation. Little is known about their immune system at birth or in the long term. Twenty‐eight children born to female kidney recipients and 40 full‐term children born to healthy mothers were evaluated. T, B, NK, NKT, γδT cells were assessed by flow cytometry and functional evaluation of T and dendritic cells after in vitro activation was performed at birth and at 8 months of age. At birth, infants born to female kidney recipients showed lower numbers of CD4+ T, NKT and intense reduction of B cells (median cells/mm3, transplant: 153.7 X control: 512.4; p < 0.001). There was also a reduced percentage of activated CD8+ T and of CD4+ regulatory T cells. Activated memory and exhausted memory B cells showed higher percentages among children exposed to immunosuppressors when compared to control group. At 8 months, most immune alterations were no longer observed, but four children still had low numbers of some lymphocyte subsets at this age. Children born to female kidney recipients had 4.351 (95% CI: 1.026–15.225; p = 0.046) higher risk of hospital admission in the first months of life—some, with severe clinical manifestations—than those born to healthy women. 相似文献
98.
Outcome of Transplantation Using Organs From Donors Infected or Colonized With Carbapenem‐Resistant Gram‐Negative Bacteria 下载免费PDF全文
A. Mularoni A. Bertani G. Vizzini F. Gona M. Campanella M. Spada S. Gruttadauria P. Vitulo P. Conaldi A. Luca B. Gridelli P. Grossi 《American journal of transplantation》2015,15(10):2674-2682
Donor‐derived infections due to multidrug‐resistant bacteria are a growing problem in solid organ transplantation, and optimal management options are not clear. In a 2‐year period, 30/214 (14%) recipients received an organ from 18/170 (10.5%) deceased donors with infection or colonization caused by a carbapenem‐resistant gram‐negative bacteria that was unknown at the time of transplantation. Among them, 14/30 recipients (47%) received a transplant from a donor with bacteremia or with infection/colonization of the transplanted organ and were considered at high risk of donor‐derived infection transmission. The remaining 16/30 (53%) recipients received an organ from a nonbacteremic donor with colonization of a nontransplanted organ and were considered at low risk of infection transmission. Proven transmission occurred in 4 of the 14 high‐risk recipients because donor infection was either not recognized, underestimated, or not communicated. These recipients received late, short or inappropriate posttransplant antibiotic therapy. Transmission did not occur in high‐risk recipients who received appropriate and prompt antibiotic therapy for at least 7 days. The safe use of organs from donors with multidrug‐resistant bacteria requires intra‐ and inter‐institutional communication to allow appropriate management and prompt treatment of recipients in order to avoid transmission of infection. 相似文献
99.
E. S. Christenson B. Teply V. Agrawal P. Illei A. Gurakar J. A. Kanakry 《American journal of transplantation》2015,15(10):2762-2766
Primary effusion lymphoma is a rare subclass of non‐Hodgkin lymphoma associated with human herpesvirus 8 infection and principally seen in human immunodeficiency virus–positive patients. We report on the case of a 72‐year‐old human immunodeficiency virus–negative male with a hepatic transplant 10 years prior, who presented with a symptomatic right‐sided pleural effusion and was found to have primary effusion lymphoma by flow cytometric and cytopathologic examination. Immunohistochemistry of his lymphoma cells was positive for human herpesvirus 8. Both he and his donor had no identifiable risk factors for human herpesvirus 8 infection. The patient was intolerant of antiviral therapy and chemotherapy, dying 7 months after diagnosis. Posttransplant primary effusion lymphoma is exceedingly rare and carries a very poor prognosis. Individualized treatment strategies are necessary given the scant body of published literature with guidance based solely on case reports. 相似文献
100.